NCT02268214 Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes Status COMPLETED Phase PHASE3
NCT02264678 Ascending Doses of Ceralasertib in Combination With Chemotherapy and/or Novel Anti Cancer Agents Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02260661 Phase I, Dose Study to Look at the Safety and Pharmacokinetics of AZD8835 in Patients With Advanced Solid Tumours Status COMPLETED Phase PHASE1
NCT02258542 A Safety Extension Study to Evaluate the Safety and Tolerability of Benralizumab (MEDI-563) in Asthmatic Adults and Adolescents on Inhaled Corticosteroid Plus LABA Status COMPLETED Phase PHASE3
NCT02253121 Glucose Control During Glucocorticoid Therapy in Acute Exacerbation of Chronic Obstructive Pulmonary Disease Status COMPLETED Phase PHASE4
NCT02252913 A Study of Safety and Pharmacokinetics of Volitinib With Docetaxel in Patients With Advanced Gastric Cancer Status COMPLETED Phase PHASE1
NCT02249936 A Phase 1 Study to Examine the Pharmacodynamics of Different AZD1722 Formulations Status COMPLETED Phase PHASE1
NCT02248909 Non-interventional Study of Spirometry Use to Diagnose COPD (Chronic Obstructive Pulmonary Disease) and to Prescribe Treatment to COPD Patients in the Outpatient Institutions Status COMPLETED Phase N/A
NCT02245737 An Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease Status TERMINATED Phase PHASE2/PHASE3
NCT02243176 24-Week, Multicenter, Randomized, Parallel-group, Open-label, Active Controlled Phase IV Study to Assess the Efficacy, Safety and Tolerability of Saxagliptin Compared With Acarbose When in Combination With Metformin in Patients With T2D Inadequately Controlled With Metformin Monotherapy Status COMPLETED Phase PHASE4
NCT02239666 Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis Status COMPLETED Phase N/A
NCT02238782 A Study to Assess the Absolute Bioavailability of Oral Selumetinib in Healthy Male Volunteers. Status COMPLETED Phase PHASE1
NCT02238483 A Phase IIa Study to Investigate the Efficacy and Safety of AZD7624 in Chronic Obstructive Pulmonary Disease (COPD) Patients While on Maintenance Therapy Status COMPLETED Phase PHASE2